Company Filing History:
Years Active: 2016
Title: Byoung Gon Moon: Innovating Transgenics in Daejeon
Introduction
Byoung Gon Moon is a distinguished inventor based in Daejeon, South Korea, recognized for his pivotal contributions to transgenic technology. With a focus on enhancing medical applications, he has developed innovative solutions that promise to advance the field of xenotransplantation.
Latest Patents
Byoung Gon Moon holds a notable patent titled "Transgenic pig expressing sTNFR1-Fc genes and the uses thereof." This groundbreaking invention involves a transgenic pig engineered to express the sTNFR1-Fc gene. This gene encodes a fusion protein composed of the extracellular domain of the human soluble tumor necrosis factor receptor (sTNFR1) and an immunoglobulin Fc region. The patent outlines methods for producing the transgenic pig, isolating organs, and preparing blood samples containing sTNFR1-Fc, facilitating the effective use of this technology for suppressing immune and inflammatory responses.
Career Highlights
Currently, Byoung Gon Moon is affiliated with the Snur & Db Foundation, where he continues to push the boundaries of biotechnology. His work focuses on how transgenic pigs can secrete an inhibitory substance that diminishes the activity of tumor necrosis factor alpha (TNF-α) in blood. This breakthrough opens avenues for successful xenotransplant options, especially since the transgenic pigs possess blood type O, making them compatible with a broader range of recipients.
Collaborations
During his career, Byoung Gon Moon has collaborated with notable colleagues, including Curie Ahn and Byeong Chun Lee. Their collective efforts in research contribute greatly to their shared goal of advancing biotechnological innovations.
Conclusion
Byoung Gon Moon's contributions to the field of transgenics reflect the potential of biotechnology to address critical challenges in medicine. With a blend of innovative thinking and collaborative efforts, he paves the way for future advancements that may redefine transplant science and improve patient outcomes in the face of disease.